The drugs are injectables and cost between $1200 and $1500 per month out of pocket
Fanelli G, Franke B, De Witte W, Ruisch IH, Haavik J, van Gils V, et al
There was evidence of a significant reduction in average loop diuretic dose, a lower likelihood of diuretic treatment escalation, and a greater likelihood of diuretic treatment de-escalation with semaglutide versus placebo parameters that indicate disease-modifying effects of semaglutide, and are associated with better long-term clinical outcomes in this patient population. Kavita Sharma, MD, study author In this secondary analysis of the STEP-HFpEF program data, researchers found that both male and female participants experienced notable improvements in heart failure symptoms, physical limitations, and exercise
NIDDK Prescription Medications to Treat Overweight & Obesity U.S